Leyre Bento

Servicio de Hematología, Hospital Universitario Son Espases

[Aaron Logan, MD, PhD, MPhil @hemedoc]

#ASH19 #bmtsm Horowitz: the BMT field realized long ago that every question can’t feasibly be addressed in trials. The @CIBMTR registry has become invaluable.

[Aaron Logan, MD, PhD, MPhil @hemedoc]

#ASH19 #bmtsm Horowitz: when donor age implicated in outcomes, field shifted to selecting mostly donors <35yo. None of these studies could have been done without CUBMTR registry and they have had significant impact on patient outcomes.